Patents by Inventor Davor Brinc

Davor Brinc has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8597636
    Abstract: A method of cell-based therapy for treating an autoimmune disease is disclosed. The method is directed at stimulating leukocytes and/or dendritic cells to interrupt autoimmunity in a host. The method provides a Fc? receptor-specific complex or a complex which results in the co-crosslinking of Fc?-chains for treating the leukocytes and/or dendritic cells which are in turn used to elicit an autoimmune interruption response in a subject with an autoimmune disease. The Fc? receptor-specific complex and/or complex which results in the co-crosslinking of Fc?-chains is used to treat a biological sample comprising leukocytes and/or dendritic cells from a patient, and upon reintroducing said biological sample to the patient, the pre-treated dendritic cells illicit an autoimmune interruption response in vivo.
    Type: Grant
    Filed: January 16, 2007
    Date of Patent: December 3, 2013
    Assignee: Canadian Blood Services
    Inventors: Alan H. Lazarus, Vinayakumar Siragam, Davor Brinc, John Freedman, Andrew R. Crow, Seng Song
  • Publication number: 20080050391
    Abstract: A method for treating autoimmune diseases in a mammal which method comprises administering to the mammal an effective amount of at least one antibody specific for a soluble antigen is provided. Furthermore, a novel mechanism of action has been established in accordance with the present invention for antibody-based treatment regimes for autoimmune disease, including but not limited to anti-CD44 and soluble antigen specific antibody treatment regimes.
    Type: Application
    Filed: March 30, 2005
    Publication date: February 28, 2008
    Inventors: Alan H. Lazarus, Seng Song, Andrew R. Crow, Vinayakumar Siragam, Davor Brinc, John Freedman
  • Publication number: 20070207128
    Abstract: A method of cell-based therapy for treating an autoimmune disease is disclosed. The method is directed at stimulating leukocytes and/or dendritic cells to interrupt autoimmunity in a host. The method provides a Fc? receptor-specific complex or a complex which results in the co-crosslinking of Fc?-chains for treating the leukocytes and/or dendritic cells which are in turn used to elicit an autoimmune interruption response in a subject with an autoimmune disease. The Fc? receptor-specific complex and/or complex which results in the co-crosslinking of Fc?-chains is used to treat a biological sample comprising leukocytes and/or dendritic cells from a patient, and upon reintroducing said biological sample to the patient, the pre-treated dendritic cells illicit an autoimmune interruption response in vivo.
    Type: Application
    Filed: January 16, 2007
    Publication date: September 6, 2007
    Inventors: Alan Lazarus, Vinayakumar Siragam, Davor Brinc, John Freedman, Andrew Crow, Seng Song